Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia (CLL)

Explore clinical trials studying Chronic Lymphocytic Leukemia (CLL). Study availability and eligibility vary by location and protocol.

72 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia (CLL) trial results

Recruiting

Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

NCT03824483

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
Locations
  • Northwestern University Evanston, Illinois, United States
  • Massachusetts General Hospital (Data Collection and Specimen Analysis) Boston, Massachusetts, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details
Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

NCT04830137

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +36 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver, Colorado, United States
View all 16 locations
View Trial Details
Recruiting

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

NCT04895436

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 230157 La Jolla, California, United States
  • Winship Cancer Institute of Emory University /ID# 230643 Atlanta, Georgia, United States
  • Des Moines Oncology Research Association /ID# 232606 Des Moines, Iowa, United States
  • Dana-Farber Cancer Institute /ID# 230061 Boston, Massachusetts, United States
View all 58 locations
View Trial Details
Recruiting

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT02966756

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +16 more
Locations
  • Concord Repatriation General Hospital /ID# 201261 Concord, New South Wales, Australia
  • St George Hospital /ID# 206484 Kogarah, New South Wales, Australia
  • Monash Health - Monash Medical Centre /ID# 201263 Clayton, Victoria, Australia
  • Anhui Provincial Cancer Hospital /ID# 209458 Hefei, Anhui, China
View all 31 locations
View Trial Details
Recruiting

Zanubrutinib and Venetoclax in CLL (ZANU-VEN)

NCT05168930

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
Locations
  • New England Cancer Specialists Scarborough, Maine, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • South Shore Hospital South Weymouth, Massachusetts, United States
View Trial Details
Recruiting

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT05908409

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
Locations
  • Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario de Salamanca Salamanca, Castille and León, Spain
  • Hospital Universitari Vall d'hebron Barcelona, Spain
  • Hospital Durán i Reynals - ICO L´Hospitalet Barcelona, Spain
View Trial Details

Related conditions